Markus Schindler

Novo Nordisk, Executive Vice-President, Chief Scientific Officer

Holding a PhD in Pharmacology from the University of Cambridge, he has 25 years of leadership experience in the pharmaceutical industry. Since March 2021, he is heading Research & Early Development activities at Novo Nordisk.